Constellation Pharmaceuticals

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.

Total Funding

$309.5 M

Type

Private

Cambridge, US

Founded

2008

Size (employees)

72 (est)

Website

constellationpharma.com

Constellation Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US

Report incorrect company information

Key People/Management at Constellation Pharmaceuticals

Jigar Raythatha

President & Chief Executive Officer

Matthias Jaffe

CFO

Mark A. Goldsmith

Executive Chairman

James Audia

Chief Scientific Officer

Brenda Sousa

Vice President of Human Resources

Report incorrect company information

Constellation Pharmaceuticals Office Locations

Constellation Pharmaceuticals has an office in Cambridge

Cambridge, US (HQ)

215 First St

Show all (1)

Report incorrect company information

Constellation Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date	2008
Total Funding	$309.5 m
Latest funding size	$100 m
Time since last funding	2 months ago
Investors	Topspin Partners, Deerfield Management, SROne, Fidelity Management and Research Company, NS Investment, Venrock Healthcare Partners, Third Rock Ventures, OrbiMed, Hillhouse Capital, Casdin Capital, Venrock, SR One, Genentech, University of California Investment Office, Solon Mack Capital, Cormorant Asset Management, Sirona Capital, Altitude Life Science Ventures, The Column Group

Constellation Pharmaceuticals's latest funding round in April 2018 was reported to be $100 m. In total, Constellation Pharmaceuticals has raised $309.5 m

Show all financial metrics

Report incorrect company information